RENAISSANCE TECHNOLOGIES LLC

Position in IBIO — iBio, Inc.

CIK 1037389 NEW YORK, NY

Position in IBIO

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$354,982

-$326,962 QoQ

Shares Held

202,847

-42.6% QoQ

Ownership

0.315%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#27

of 55 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. IBIO ranks #229 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$354,982	202,847	-42.6%	Shares	Sole	2026-08-13
2025-12-31	$681,944	353,339	+2125.2%	Shares	Sole	2026-02-12
2024-03-31	$64,468	15,879	-65.6%	Shares	Sole	2024-05-13
2023-06-30	$28,121	46,100	-32.1%	Shares	Sole	2023-08-11
2023-03-31	$141,232	67,900	-82.2%	Shares	Sole	2023-05-12
2022-12-31	$167,901	381,595	-70.4%	Shares	Sole	2023-02-13
2022-09-30	$218,930	1,287,827	+11.9%	Shares	Sole	2022-11-14
2022-06-30	$299,358	1,151,377	+164.6%	Shares	Sole	2022-08-12
2022-03-31	$187,085	435,082	+186.8%	Shares	Sole	2022-05-13
2021-09-30	$160,820	151,717	+278.7%	Shares	Sole	2021-11-12
2020-03-31	$42,466	40,063	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.